Cirrhosis Natural History: After the First Decompensation, the Disease Trajectory Accelerates: Hepatology Communications | October 2026

What Did the Study Find?

This CORE Consortium study followed 1,777 patients with compensated advanced chronic liver disease (cACLD), defined by liver stiffness ≥15 kPa, across 19 international centres and used multistate modelling to track progression from compensation → first decompensation → second decompensation → death.

• Over a median 4.25 years, 14.9% developed a first hepatic decompensation.
• From compensated disease, the rate of first decompensation was relatively low at 3.10 per 100 person-years.
• Death while still compensated occurred at 1.01 per 100 person-years.
• The major inflection point was the first decompensation.
• Once this occurred, the rate of a second decompensation surged to 42.73 per 100 person-years—more than 10-fold higher than the initial decompensation rate.
• Decompensation included ascites, hepatic encephalopathy, spontaneous bacterial peritonitis or variceal bleeding.
• Disease trajectory also varied by etiology.
• Alcohol-associated liver disease showed the highest rate of progression from cACLD to first decompensation.
• HBV-related disease had the lowest progression rate from first to second decompensation.

Why Does It Matter?

Cirrhosis should not be viewed as a single static stage. Most patients with cACLD may remain compensated for prolonged periods, but the first decompensating event fundamentally changes prognosis and signals a rapidly accelerating disease course.

Traditional studies focusing only on “time to first decompensation” can therefore miss clinically important subsequent transitions.

GastroAGI Takeaway

The first hepatic decompensation is the critical turning point in the natural history of cirrhosis.

Before decompensation, progression is relatively slow; afterward, the risk of another decompensating event rises dramatically. This supports a stage-dependent approach to cirrhosis care: prevent first decompensation aggressively during cACLD, but once decompensation occurs, rapidly intensify management, reassess prognosis and consider timely liver-transplant evaluation rather than waiting for repeated events.